Onshoring: Drugmakers seek enhancements to FDA’s PreCheck program
Regulatory NewsJoanne S. Eglovitch
Audit/inspectionBiologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)ComplianceManufacturingPharmaceuticalsProduct developmentQuality Assurance and ControlRegulatory Intelligence/PolicySubmission and registrationUnited StatesUS Food and Drug Administration (FDA)